Radiochemicals
Description
Radioactive strontium therapy with Sr-89 treats cancers that have spread to the bone. The radioactive strontium targets the cancer cells in the bone. Strontium Chloride Sr-89 is indicated for the relief of bone pain in patients with painful skeletal metastases.
Status
Inquire
Radionuclidic purity
> 99.0%
Radiochemical purity
>—%
Chemical formula
SrCl2
Concentration
> 10 mCi/ml
Specific activity
—
Half life
50.57 days
Calibration
—
Form
0.1-0.5 M HCl solution
Regions
Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, USA
Initial activity
mCi
Elapsed time
days
Final activity